AU4198693A - Sustained release formulations - Google Patents

Sustained release formulations

Info

Publication number
AU4198693A
AU4198693A AU41986/93A AU4198693A AU4198693A AU 4198693 A AU4198693 A AU 4198693A AU 41986/93 A AU41986/93 A AU 41986/93A AU 4198693 A AU4198693 A AU 4198693A AU 4198693 A AU4198693 A AU 4198693A
Authority
AU
Australia
Prior art keywords
sustained release
release formulations
formulations
sustained
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU41986/93A
Other versions
AU663388B2 (en
Inventor
David Bodmer
Jones Wing Fong
Thomas Kissel
Hawkins Valliant Maulding
Oskar Nagele
Jane Edna Pearson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4198693A publication Critical patent/AU4198693A/en
Application granted granted Critical
Publication of AU663388B2 publication Critical patent/AU663388B2/en
Assigned to NOVARTIS AG reassignment NOVARTIS AG Request to Amend Deed and Register Assignors: SANDOZ LTD.
Adjusted expiration legal-status Critical
Expired legal-status Critical Current

Links

AU41986/93A 1989-07-07 1993-07-15 Sustained release formulations Expired AU663388B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37702389A 1989-07-07 1989-07-07
US411347 1989-09-22
US377023 1989-09-22

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU58746/90A Division AU641407B2 (en) 1989-07-07 1990-07-05 Octreotide-pamoate

Publications (2)

Publication Number Publication Date
AU4198693A true AU4198693A (en) 1993-09-23
AU663388B2 AU663388B2 (en) 1995-10-05

Family

ID=23487449

Family Applications (2)

Application Number Title Priority Date Filing Date
AU41986/93A Expired AU663388B2 (en) 1989-07-07 1993-07-15 Sustained release formulations
AU41985/93A Expired AU662825B2 (en) 1989-07-07 1993-07-15 Process for the production of microparticles

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU41985/93A Expired AU662825B2 (en) 1989-07-07 1993-07-15 Process for the production of microparticles

Country Status (3)

Country Link
AU (2) AU663388B2 (en)
SA (1) SA90110050B1 (en)
ZA (1) ZA905327B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
JPH023631Y2 (en) * 1984-12-28 1990-01-29

Also Published As

Publication number Publication date
ZA905327B (en) 1992-03-25
AU663388B2 (en) 1995-10-05
SA90110050B1 (en) 2002-11-23
AU662825B2 (en) 1995-09-14
AU4198593A (en) 1993-09-23

Similar Documents

Publication Publication Date Title
AU8131191A (en) Sustained release formulations
AU639947B2 (en) Sustained release elements
AU622526B2 (en) Sustained release pharmaceutical preparation
AU5939394A (en) Sustained release compositions
AU2164088A (en) Controlled release formulations
AU6605894A (en) Opiod formulations having extended controlled release
AU2707788A (en) Sustained release pharmaceutical composition
AU1219388A (en) Sustained release matrix formulations
AU6486490A (en) Formulations for sustained release dressings and their use
AU8554691A (en) Improved formulations
AU1118092A (en) Sustained release compositions
GB8908250D0 (en) Formulations
AU8130391A (en) Solid formulations
AU6111390A (en) Pesticidal formulations
AU5943990A (en) Sustained release pharmaceutical compositions
AU4664889A (en) Sustained release diltiazem formulation
AU7942087A (en) Sustained release formulations
AU5870090A (en) Topical formulations
AU609660B2 (en) Antiparasitic formulations
AU2431388A (en) Somototropin formulations
AU627847B2 (en) Pesticidal formulations
AU8438091A (en) Slow release compositions
AU663388B2 (en) Sustained release formulations
AU634086B2 (en) Gemfibrozil formulations
AU641509B2 (en) Gemfibrozil formulations

Legal Events

Date Code Title Description
NDA Extension of term for standard patent accepted (sect.70)

Free format text: PRODUCT NAME: SANDOSTATIN LAR (OCTREOTIDE)

Extension date: 20141224

NDB Extension of term for standard patent granted (sect.76)

Free format text: PRODUCT NAME: SANDOSTATIN LAR (OCTREOTIDE)

Extension date: 20141224